glp 1 for eating disorders The rapid rise of GLP-1 receptor agonists presents a complex dilemma clinicians managing patients with disorders. While these medications show potential in reducing binge eating behaviors by targeting brain reward Treating Eating Disorder Clients Amid

By 2035, non-Hispanic Black females are projected to reach 59.5%

Always follow the prescribed dosage and administration instructions, and promptly report any side effects or concerns to your healthcare provider for appropriate management and guidance

Streaks that build momentum Your streak grows every day you log something, a meal, your water, a check-in, or your weight

Sensitivity analyses generally supported the primary findings

In the second trial, SURPASS-2, tirzepatide administered at doses of 5 mg, 10 mg, or 15 mg showed superior efficacy compared to semaglutide (1 mg) in reducing body weight and HbA1c levels over 40 weeks in patients with T2DM inadequately controlled with metformin [66]

Always review the injection instructions included with your package of semaglutide